Sep 09, 2019 / 01:20PM GMT
Unidentified Analyst -
Good morning, everybody. Thanks for joining us for the next session. Pleased to have Autolus with us. Quickly before we get started, I just need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures or you can pick up a copy at the registration desk.
So Christian, pleased to have you with us. Christian is the CEO of Autolus.
Questions and Answers:
Unidentified Analyst -And I thought maybe just to start us off, there's lots of cell therapy companies out there, there's a lot of investment in cell therapy. Maybe you could just broadly talk about what you think differentiates Autolus in your approach versus some of the other cell therapy companies out there?
Christian Martin Itin - Autolus Therapeutics plc - Chairman & CEO
Well, first of all, thanks for having us at the conference, a real pleasure. You're absolutely